NKG2D upregulation sensitizes tumors to combined anti-PD1 and anti-VEGF therapy and prevents hearing loss. - Lu S; Yin Z; Wu L; Sun Y; Chen J; Wu LMN; Oblinger JL; Blake DC; Xiu B; Landegger LD; Seist R; Ho W; et al. (Nature communications, 2026)